Combo Products Face Costlier Process Under Europe’s New MDD – Alcon Exec
This article was originally published in The Gray Sheet
The combination product policy outlined in the proposed revisions to Europe's Medical Devices Directive is emerging as a leading industry concern
You may also be interested in...
Comments from AdvaMed and its European counterpart Eucomed raise concerns about device reclassifications appearing in the revised Medical Devices Directive
A draft revision of the European Medical Devices Directive would give manufacturers of implantable and Class III devices less leeway to avoid clinical evaluation requirements
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.